![Dr Yousuf Mohammed](/sites/default/files/profiles/11844.jpeg)
Overview
Background
Dr Yousuf Mohammed completed his PhD in pharmaceutics and skin drug delivery under the guidance of Associate prof Heather Benson, Prof Michael Roberts and Associate prof Tarl Prow. He has been working within the field of skin delivery at the Therapeutics Research Centre, University of Queensland - School of Medicine since 2012. His current research includes managing a five-year (2018-2023) US FDA funded project titled Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations as a Principle Investigator and managing the five-year project (2014-2019) Characterization of Critical Quality Attributes for Semisolid Topical Drug Products as a Co-investigator. These projects aims to improve current regulatory guidelines for topical and transdermal semisolid products. Over the last 6 years, his work has been focused on skin penetration and skin toxicology of drugs and xenobiotics including nanoparticulate materials.
Availability
- Dr Yousuf Mohammed is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Masters (Coursework), Curtin University of Technology
- Doctor of Philosophy, Curtin University of Technology
Research interests
-
Bioequivalence of Topical products: Elucidating the sensorial and functional characteristics of Topical Formulations
In addition to the defined therapeutic effect caused by an active drug in a product, there is also a placebo and, potentially, a nocebo effect associated with those products. In topical products, these latter effects may account from 30% to 50% of the overall response for some products. They may also explain why some topical products with apparently identical bioavailability are associated with different patient outcomes. This application seeks to address the question of when do subtle excipient and manufacturing changes in a topical product cause a sensorial sensation by subjects that the “feel” of a product has changed either before and/or after it is applied to human skin. A second question is whether the “feel” of a product both before and after application can be quantified by instrumental rheology, tribology and texture analysis methods and whether these, in turn, can be related to the reported sensorial behaviour. We will manufacture topical formulations that systematically vary in Q1, Q2, and/or Q3 attributes and have large and borderline perceptive differences. We will then characterized these products using a range of rheology, tribology and texture analysis methods. In parallel, these products will be evaluated by perceptive testing focus groups, with controls, of their sensorial characterisation of the ‘feel’ of the products. We will then relate these sensorial findings with the variations in formulation nature, composition and manufacture, and their resulting instrumental test results. Our goals are, firstly, to understand the relationships between product nature, instrumental findings and sensorial analyses and, secondly, to derive criteria for instrument tests that indicates what product composition subjects suggest do not differ, uncertain if they differ and do differ in their sensorial behaviour. It is hoped that we can define the simplest, robust test that accurately and robustly is in line with sensory perceptions. A range of statistical methods, including (potentially) sophisticated, machine learning and deep learning tools will then be used to model the most appropriate instrumental analysis that can, with reasonable confidence predict perceptive attributes. A key outcome is a potential regulatory guideline advocating that generic products should exhibit similar sensorial behaviour as a reference listed drug product, giving boundaries in rheology, tribology and texture analysis as defined by Q1, Q2 and Q3 differences when that sensorial behaviour between topical products is likely to be different.
-
Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations
The general requirements for generics to be considered are that the product is off-patent, contains an active ingredient in a previously approved medicine and is shown to be bioequivalent to that previously approved medicine. The fundamental forces governing the effects of topical drugs applied to the skin can be summed up in three distinct dimensions. 1. The interaction of the active pharmaceutical ingredient (API) with the excipients (formulation factors, solubility), 2. API with the skin (thermodynamic and pharmacodynamic activity) and 3. Excipient with the skin (penetration enhancement, diffusivity, irritancy). A thoughtful appreciation followed by a thorough understanding and then careful deliberations can help mitigate a number of failure modes that can arise from these three dimensions and result in disapproval of generic drug applications. However, there is an elusive fourth dimension, the psychorheology or the sensory/perceptive judgement of the rheological properties (and other organoleptic properties) that dictates the end user/consumers final acceptance of the product. Through this project we aim to develop meaningful risk mitigating methods and their scientific basis. These will encompass considering product behaviour during various stages of development/manufacturing, all the way to looking at the metamorphosing product as it is being applied to the treatment site on the skin. The development of generic topical products has been hampered by factors such as expensive clinical trials for BE assessment and application costs which get blown out due to the case by case assessment of applications. A burdensome application package is generally needed that wastes valuable resources and time on both sides of the coin. This project will ensure the much needed theoretical and practical framework that can enable a thorough yet efficient assessment of topical generic product applications.
-
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products
This US FDA funded project aims to understand the formulation-drug-skin interactions. Certain physicochemical attributes of a pharmaceutical product can be deemed as Critical Quality Attributes based on their influence of the product performance. This 5 year project goes into 16 different quality attributes and tests for their role in the performance of topical products using 22 different tests and numerous instruments and methods.
-
Toxicology of topically applied nanoparticles
The safety of nanoparticles used in sunscreens has been a controversial international issue in recent years, in part because previous animal exposure studies generally found much higher skin absorption of zinc from dermal application of ZnO sunscreens than human studies. Our group’s work for the last several years has challenged these false alarms and through evidence based volunteer studies, provided the vital confidence boosting evidence for safe use of sunscreens. This is particularly relevant as the typical exposure to dangerous UV radiations has been on the rise.
Research impacts
Dr Yousuf Mohammed completed his PhD in pharmaceutics and skin drug delivery under the guidance of Associate prof Heather Benson, Prof Michael Roberts and Associate prof Tarl Prow. He has been working within the field of skin delivery at the Therapeutics Research Centre, University of Queensland - School of Medicine since 2012. His current research includes managing a five-year (2018-2023) US FDA funded project titled Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations as a Principle Investigator and managing a four-year (2019-2023) US FDA funded project titled Bioequivalence of Topical products: Elucidating the sensorial and functional characteristics of Topical Formulations as a Principle Investigator. He is also currently managing the five-year project (2014-2019) Characterization of Critical Quality Attributes for Semisolid Topical Drug Products as a Co-investigator. These projects aims to improve current regulatory guidelines for topical and transdermal semisolid products in its second year of No Cost Extension. Over the last 6 years, his work has been focused on skin penetration and skin toxicology of drugs and xenobiotics including nanoparticulate materials.
Working on the US FDA project over the last two years has given an opportunity to showcase real world translational research. The work Yousuf and team has done has led to FDA guidance for Acyclovir creams which highlight the novel methods developed as a part of the work carried out locally in Brisbane in between TRI and other labs in the St Lucia campus.
Role of dispensers on physicochemical properties of the cream when dispensed. Difference in product performance upon dispensing from different dispensers was first identified and reported by our group and the change in cream product guidance based on this work is one of the biggest achievements. Our work over the last couple of years and specifically in the current year (July 2016- June 2017) has also identified skin and drug properties that determine product performance. Of special mention is our work on testing IVPT performance with different doses, different skin membrane types and different sampling protocols and different study durations. This a part of grant’s Aim 3 where we proposed to develop ideal IVPT conditions based on careful literature review as well as clearly thought-out experiments to investigate each parameter that can effect a products performance. Our IVPT studies have also included developing in-use product application and testing protocols and have assessed direct comparisons of CQAs with product performance.
Locally within the Australian topical and consumer product regulatory scene, Dr Mohammed’s work published in the Journal of Investigative dermatology has helped dispel false alarms regarding the safety and toxicity of ZnO nanoparticles. The story was captured by numerous (>400) printed and online media articles. This work, coming out at the peak of summer in Australia led to improved consumer confidence regarding better sun protection habits.
Works
Search Professor Yousuf Mohammed’s works on UQ eSpace
2024
Journal Article
Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies
Paudel, Keshav Raj, Singh, Manisha, De Rubis, Gabriele, Kumbhar, Popat, Mehndiratta, Samir, Kokkinis, Sofia, El-Sherkawi, Tammam, Gupta, Gaurav, Singh, Sachin Kumar, Malik, Md. Zubbair, Mohammed, Yousuf, Oliver, Brian G., Disouza, John, Patravale, Vandana, Hansbro, Philip Michael and Dua, Kamal (2024). Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies. Life Sciences, 352 122859, 122859. doi: 10.1016/j.lfs.2024.122859
2024
Journal Article
Strategic Approaches in Formulation Development for Atopic Dermatitis
Kurebayashi, Alberto Keidi, Phan, Khanh, Abdoh, Ayyah, Andreo-Filho, Newton, Lopes, Patricia Santos, Mohammed, Yousuf and Leite-Silva, Vania Rodrigues (2024). Strategic Approaches in Formulation Development for Atopic Dermatitis. Cosmetics, 11 (4) 113, 113. doi: 10.3390/cosmetics11040113
2024
Journal Article
Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?
Jha, Saurav Kumar, Imran, Mohammad, Anwaar, Shoaib, Hansbro, Philip M, Paudel, Keshav Raj and Mohammed, Yousuf (2024). Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?. Nanomedicine, ahead-of-print (ahead-of-print), 1-4. doi: 10.1080/17435889.2024.2369495
2024
Journal Article
Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I—Bioequivalence of Acyclovir Topical Creams
Mohammed, Y. H., Namjoshi, S. N., Jung, N., Windbergs, M., Benson, H. A. E., Grice, J. E., Raney, S. G. and Roberts, M. S. (2024). Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I—Bioequivalence of Acyclovir Topical Creams. Pharmaceutical Research, 41 (7), 1-14. doi: 10.1007/s11095-024-03736-9
2024
Journal Article
Gamma scintigraphy in sensing drug delivery systems
Nadaf, Arif, Jiba, Umme, Chaudhary, Arshi, Hasan, Nazeer, Adil, Mohammad, Mohammed, Yousuf Hussain, Kesharwani, Prashant, jain, Gaurav Kumar and Ahmad, Farhan Jalees (2024). Gamma scintigraphy in sensing drug delivery systems. Nuclear Engineering and Technology. doi: 10.1016/j.net.2024.06.004
2024
Journal Article
Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery
Gunjal, Pradnya, Vishwas, Sukriti, Kumar, Rajan, Bashir, Bushra, Kumar, Bimlesh, Khurana, Navneet, Gulati, Monica, Gupta, Gaurav, Prasher, Parteek, Kumbhar, Popat, Disouza, John, Kuppusamy, Gowthamarajan, Mohammed, Yousuf, Dureja, Harish, Dua, Kamal and Singh, Sachin Kumar (2024). Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery. Drug Delivery and Translational Research, 1-17. doi: 10.1007/s13346-024-01634-6
2024
Journal Article
Microsponges: Development, Characterization, and Key Physicochemical Properties
Qureshi, Sundus, Alavi, Seyed Ebrahim and Mohammed, Yousuf (2024). Microsponges: Development, Characterization, and Key Physicochemical Properties. ASSAY and Drug Development Technologies, 22 (5), 229-245. doi: 10.1089/adt.2023.052
2024
Journal Article
Enhancement of drug permeation across skin through stratum corneum ablation
Abdoh, Ayyah, Liu, David and Mohammed, Yousuf (2024). Enhancement of drug permeation across skin through stratum corneum ablation. RSC Pharmaceutics, 1 (2), 151-160. doi: 10.1039/d4pm00089g
2023
Journal Article
Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures
Hasan, Nazeer, Imran, Mohammad, Jain, Dhara, Jha, Saurav Kumar, Nadaf, Arif, Chaudhary, Arshi, Rafiya, Km, Jha, Laxmi Akhileshwar, Almalki, Waleed H., Mohammed, Yousuf, Kesharwani, Prashant and Ahmad, Farhan Jalees (2023). Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures. Environmental Research, 238 (Pt 1) 117007, 1-10. doi: 10.1016/j.envres.2023.117007
2023
Journal Article
Innovative approaches for maintaining and enhancing skin health and managing skin diseases through microbiome-targeted strategies
AL-Smadi, Khadeejeh, Leite-Silva, Vania Rodrigues, Filho, Newton Andreo, Lopes, Patricia Santos and Mohammed, Yousuf (2023). Innovative approaches for maintaining and enhancing skin health and managing skin diseases through microbiome-targeted strategies. Antibiotics, 12 (12) 1698. doi: 10.3390/antibiotics12121698
2023
Journal Article
Porous silicon embedded in a thermoresponsive hydrogel for intranasal delivery of lipophilic drugs to treat rhinosinusitis
Bakshi, Shrishty, Pandey, Preeti, Mohammed, Yousuf, Wang, Joanna, Sailor, Michael J., Popat, Amirali, Parekh, Harendra S. and Kumeria, Tushar (2023). Porous silicon embedded in a thermoresponsive hydrogel for intranasal delivery of lipophilic drugs to treat rhinosinusitis. Journal of Controlled Release, 363, 452-463. doi: 10.1016/j.jconrel.2023.09.045
2023
Journal Article
A comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response
Jha, Saurav Kumar, Imran, Mohammad, Jha, Laxmi Akhileshwar, Hasan, Nazeer, Panthi, Vijay Kumar, Paudel, Keshav Raj, Almalki, Waleed H., Mohammed, Yousuf and Kesharwani, Prashant (2023). A comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response. Environmental Research, 236 (Pt 2) 116823, 1-37. doi: 10.1016/j.envres.2023.116823
2023
Journal Article
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
Hasan, Nazeer, Nadaf, Arif, Imran, Mohammad, Jiba, Umme, Sheikh, Afsana, Almalki, Waleed H., Almujri, Salem Salman, Mohammed, Yousuf Hussain, Kesharwani, Prashant and Ahmad, Farhan Jalees (2023). Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. Molecular Cancer, 22 (1) 168, 168. doi: 10.1186/s12943-023-01854-3
2023
Journal Article
Using a topical formulation of vitamin D for the treatment of vitiligo: a systematic review
Al-Smadi, Khadeejeh, Ali, Masood, Alavi, Seyed Ebrahim, Jin, Xuping, Imran, Mohammad, Leite-Silva, Vania R. and Mohammed, Yousuf (2023). Using a topical formulation of vitamin D for the treatment of vitiligo: a systematic review. Cells, 12 (19) 2387, 1-19. doi: 10.3390/cells12192387
2023
Journal Article
Human skin drug metabolism: relationships between methyl salicylate metabolism and esterase activities in IVPT skin membranes
Telaprolu, Krishna C., Grice, Jeffrey E., Mohammed, Yousuf H. and Roberts, Michael S. (2023). Human skin drug metabolism: relationships between methyl salicylate metabolism and esterase activities in IVPT skin membranes. Metabolites, 13 (8) 934, 1-12. doi: 10.3390/metabo13080934
2023
Journal Article
Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells
Fatima Qizilbash, Farheen, Sartaj, Ali, Qamar, Zufika, Kumar, Shobhit, Imran, Mohammad, Mohammed, Yousuf, Ali, Javed, Baboota, Sanjula and Ali, Asgar (2023). Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells. Journal of Drug Targeting, 31 (8), 794-816. doi: 10.1080/1061186x.2023.2243403
2023
Journal Article
Metamorphosis of topical semisolid products—understanding the role of rheological properties in drug permeation under the “in use” condition
Jin, Xuping, Alavi, Seyed Ebrahim, Shafiee, Abbas, Leite-Silva, Vania Rodrigues, Khosrotehrani, Kiarash and Mohammed, Yousuf (2023). Metamorphosis of topical semisolid products—understanding the role of rheological properties in drug permeation under the “in use” condition. Pharmaceutics, 15 (6) 1707, 1707. doi: 10.3390/pharmaceutics15061707
2023
Journal Article
Vitiligo: a review of aetiology, pathogenesis, treatment, and psychosocial impact
AL-smadi, Khadeejeh, Imran, Mohammad, Leite-Silva, Vania R. and Mohammed, Yousuf (2023). Vitiligo: a review of aetiology, pathogenesis, treatment, and psychosocial impact. Cosmetics, 10 (3) 84, 1-14. doi: 10.3390/cosmetics10030084
2023
Journal Article
The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds
Panthi, Vijay Kumar, Imran, Mohammad, Chaudhary, Arshi, Paudel, Keshav Raj and Mohammed, Yousuf (2023). The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds. Nanomedicine, 18 (4), 391-411. doi: 10.2217/nnm-2022-0281
2023
Journal Article
Exploring the remarkable chemotherapeutic potential of polyphenolic antioxidants in battling various forms of cancer
Imran, Mohammad, Insaf, Areeba, Hasan, Nazeer, Sugandhi, Vrushabh V., Shrestha, Deumaya, Paudel, Keshav Raj, Jha, Saurav Kumar, Hansbro, Philip M., Dua, Kamal, Devkota, Hari Prasad and Mohammed, Yousuf (2023). Exploring the remarkable chemotherapeutic potential of polyphenolic antioxidants in battling various forms of cancer. Molecules, 28 (8) 3475. doi: 10.3390/molecules28083475
Funding
Past funding
Supervision
Availability
- Dr Yousuf Mohammed is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Advanced microneedle platform for localized delivery
This project is an exceptionally innovative combination of pharmaceutical science, materials science, nanotechnology, and clinical science to develop a state-of-the art drug delivery technology for an optimal treatment and overdose risk management of highly potent medicinal compounds. The project will trigger a paradigm shift towards safer dosing of abuse and misuse prone drugs, which suffer from unreliable bioavailability due to solubility or permeation challenges.
-
Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations
The purpose of this project is to support the research necessary to elucidate how systematic alterations to the qualitative (Q1) and/or quantitative (Q2) composition of topical formulations impacts their physical, structural, and functional properties. A key aspect of the research relates to understanding how the thermodynamic properties of a topical dosage form change as it undergoes metamorphosis during dose application and drying on the skin, how the drug's thermodynamic activity profile during the metamorphosis of the dosage form may compare between compositionally different (non-Q1 and/or non-Q2) topical formulations, and how these and other forces may modulate the rate and extent to which topically applied drugs may become available at or near their site(s) of action in the skin. Another key aspect of the research relates to identifying and understanding other potential failure modes for bioequivalence (BE) and/or therapeutic equivalence (TE) (e.g., differences in irritation potential) that may arise between compositionally different (non-Q1 and/or non-Q2) topical formulations.
-
Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations
The purpose of this project is to support research relevant to topical semisolid drug products that will help elucidate the relationship between a product's quality attributes and its functional properties. A specific purpose is to elucidate how characterizations of the arrangement of matter, including rheological characterizations (e.g., texture analysis, tribology) may correlate with and/or be predictive of sensorial differences perceived by human subjects (or patients). Upon the successful completion of this research, it should be possible to predict, based upon product quality characterizations, whether test and reference products that may be compositionally different are likely to have a comparable look and feel, including comparable perceptions of grittiness, silky-smoothness, and cooling sensation.
Supervision history
Current supervision
-
Doctor Philosophy
Transdermal delviery of NAD+ precursor molecule Nicotinamide Mononucleotide using Advanced Microneedle arrays
Principal Advisor
-
Doctor Philosophy
Stimuli responsive drug delivery systems for topical delivery
Principal Advisor
-
Doctor Philosophy
Simultaneous absorption and evaporation PBPK models for topical drugs and inactive agents
Principal Advisor
Other advisors: Dr Abbas Shafiee
-
Doctor Philosophy
Thermodynamic dependence of Topical Formulations
Principal Advisor
Other advisors: Emeritus Professor Michael Roberts, Associate Professor Peter Moyle
-
Doctor Philosophy
Development of topical delivery system (TDS): Role of intrinsic and extrinsic factors on performance
Principal Advisor
Other advisors: Professor Roger Wepf
-
Doctor Philosophy
Strategies for Vitamin D transdermal supplementation
Principal Advisor
Completed supervision
-
2020
Doctor Philosophy
Assessment of Topical Semisolid Products to Design a Critical Quality Attributes and Performance based Evaluation Matrix
Principal Advisor
-
2023
Doctor Philosophy
Biodegradable silicon microrods for topical delivery of therapeutics
Associate Advisor
-
2021
Doctor Philosophy
Modeling approaches to predict human skin absorption of drugs and other chemicals
Associate Advisor
Other advisors: Dr Xin Liu, Emeritus Professor Michael Roberts
-
2020
Doctor Philosophy
Enhanced topical drug delivery for treatment of human melanoma
Associate Advisor
Other advisors: Emeritus Professor Ross Barnard, Emeritus Professor Michael Roberts, Associate Professor Helmut Schaider
-
2019
Doctor Philosophy
Development of optimal experimental conditions for evaluation of topical products
Associate Advisor
Other advisors: Dr Xin Liu, Emeritus Professor Michael Roberts
Media
Enquiries
Contact Dr Yousuf Mohammed directly for media enquiries about:
- Bioequivalence of Pharmaceutical Products
- Cosmetics
- Dermatology
- FLIM
- Healthcare products
- Multiphoton Microscopy
- Personal care products
- Regulatory Guidelines
- Rheology
- Skin feel
- Skin Imaging
- Skin Toxicology
- Topical Products
- Toxicology
- Tribology
- •Drug delivery devices
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: